URYL logo

United Royale Holdings Corp. (URYL)

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

URYL steht fuer United Royale Holdings Corp., ein Consumer Defensive-Unternehmen mit einem Kurs von $ (Marktkapitalisierung 0). Bewertet mit 48/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 16. März 2026
48/100 KI-Bewertung

United Royale Holdings Corp. (URYL) Konsumgueeter-Geschaeftsueberblick

CEOGary Robert Bartholomew
Mitarbeiter4
HauptsitzSpokane, US
IPO-Jahr2017

United Royale Holdings Corp., through its TrueNorth Quantum subsidiary, develops the Northern Shield platform, offering security and connectivity solutions for financial institutions and other sectors. Targeting healthcare, fintech, agtech, and wellness, the company aims to enable rapid development of decentralized applications, operating within the consumer defensive sector.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 16. März 2026

Investmentthese

United Royale Holdings Corp., through its TrueNorth Quantum subsidiary, is positioned to capitalize on the growing demand for secure and scalable decentralized applications. The Northern Shield platform targets key sectors like fintech and healthcare, offering potential for significant growth. However, with a market capitalization of $0.00B and a negative P/E ratio of -0.11, the company's financial stability and path to profitability remain uncertain. Key value drivers include successful adoption of the Northern Shield platform and expansion into new markets. The company's small size and limited resources pose potential risks to its long-term viability. Investors should closely monitor the company's ability to secure funding, attract customers, and achieve sustainable revenue growth.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Market capitalization of $0.00B indicates a micro-cap status, reflecting high risk and potential for volatility.
  • Negative P/E ratio of -0.11 suggests the company is currently not profitable.
  • The company operates in the technology sector, specifically focusing on platform-as-a-service (PaaS) offerings.
  • TrueNorth Quantum's Northern Shield platform targets high-growth sectors such as healthcare, fintech, and agtech.
  • The company's small size (4 employees) presents both opportunities for rapid growth and challenges related to resource constraints.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Proprietary Northern Shield platform.
  • Focus on high-growth sectors (fintech, healthcare, agtech).
  • Potential for first-mover advantage in the decentralized application platform market.

Schwaechen

  • Limited financial resources (market cap of $0.00B).
  • Small team size (4 employees).
  • Lack of profitability (negative P/E ratio).

Katalysatoren

  • Upcoming: Launch of new features or updates to the Northern Shield platform.
  • Upcoming: Announcement of strategic partnerships with companies in the fintech, healthcare, or agtech sectors.
  • Upcoming: Securing funding to support the company's growth initiatives.
  • Ongoing: Increasing adoption of the Northern Shield platform by new customers.
  • Ongoing: Expansion into new geographic markets.

Risiken

  • Potential: Limited financial resources may hinder the company's ability to execute its growth strategy.
  • Potential: Competition from established technology providers could erode market share.
  • Potential: Evolving regulatory landscape may impact the company's business model.
  • Ongoing: The company's small size and limited resources pose challenges to its long-term viability.
  • Ongoing: Dependence on the success of the Northern Shield platform creates concentration risk.

Wachstumschancen

  • Expansion into Healthcare Sector: The healthcare industry is increasingly adopting decentralized technologies to improve data security and interoperability. TrueNorth Quantum's Northern Shield platform can capitalize on this trend by offering secure and compliant solutions for healthcare providers. The global healthcare IT market is projected to reach $390 billion by 2024, presenting a significant opportunity for TrueNorth Quantum to gain market share by tailoring its platform to meet the specific needs of healthcare organizations.
  • Penetration of the Fintech Market: The fintech sector is rapidly evolving, with increasing demand for secure and scalable platforms to support innovative financial services. TrueNorth Quantum's Northern Shield platform can provide the necessary infrastructure for fintech companies to develop and deploy decentralized applications, such as blockchain-based payment systems and lending platforms. The global fintech market is expected to reach $305 billion by 2025, offering a substantial growth opportunity for TrueNorth Quantum.
  • Adoption in the Agtech Industry: The agricultural technology (agtech) sector is embracing digital solutions to improve efficiency and sustainability. TrueNorth Quantum's platform can facilitate the development of decentralized applications for supply chain management, precision farming, and agricultural finance. The agtech market is projected to reach $34 billion by 2027, providing a potential avenue for TrueNorth Quantum to expand its reach and diversify its revenue streams.
  • Strategic Partnerships and Alliances: Forming strategic partnerships with established players in the technology and financial services industries can accelerate the adoption of TrueNorth Quantum's Northern Shield platform. Collaborating with companies that have existing customer bases and distribution channels can provide access to new markets and increase brand awareness. These partnerships can also provide valuable resources and expertise to support the company's growth initiatives.
  • Geographic Expansion: Expanding into new geographic markets can unlock additional growth opportunities for TrueNorth Quantum. Targeting regions with high demand for decentralized technologies and strong economic growth can increase the company's revenue and market share. Focusing on emerging markets with limited access to traditional financial services can also provide a competitive advantage, as the Northern Shield platform can offer innovative solutions to address local needs.

Chancen

  • Expansion into new geographic markets.
  • Strategic partnerships with established companies.
  • Increasing demand for decentralized technologies.

Risiken

  • Competition from established technology providers.
  • Evolving regulatory landscape.
  • Economic downturn impacting IT spending.

Wettbewerbsvorteile

  • Proprietary Technology: The Northern Shield platform offers unique security and connectivity features that differentiate it from competitors.
  • First-Mover Advantage: Being an early entrant in the decentralized application platform market provides a competitive edge.
  • Industry Expertise: Deep understanding of the specific needs of the financial, healthcare, and agtech industries.

Ueber URYL

United Royale Holdings Corp., operating as TrueNorth Quantum, Inc., is a technology company based in Spokane, Washington. The company is focused on developing an enterprise platform designed to provide security, connectivity, and system compatibility, primarily targeting the back and front offices of financial institutions. TrueNorth Quantum's flagship product is the Northern Shield platform, a platform-as-a-service (PaaS) offering that enables the rapid building and scaling of decentralized applications (dApps). The Northern Shield platform is designed to serve a diverse range of industries, including healthcare, fintech, agtech, and wellness. By providing a secure and connected environment, the platform aims to facilitate the development and deployment of innovative solutions in these sectors. In addition to its platform offering, TrueNorth Quantum also provides application development services, assisting clients in building and customizing applications to meet their specific needs. Founded with the vision of creating a more secure and interconnected digital ecosystem, TrueNorth Quantum aims to address the growing demand for decentralized solutions across various industries. The company's focus on security and compatibility positions it as a potential enabler of innovation in sectors increasingly reliant on digital technologies.

Was das Unternehmen tut

  • Develops the Northern Shield platform, a platform-as-a-service (PaaS) offering.
  • Provides security, connectivity, and system compatibility solutions.
  • Enables the rapid building and scaling of decentralized applications (dApps).
  • Targets industries such as healthcare, fintech, agtech, and wellness.
  • Offers application development services to clients.
  • Focuses on providing secure and interconnected digital ecosystems.

Geschaeftsmodell

  • Platform-as-a-Service (PaaS): Generates revenue through subscriptions and usage fees for the Northern Shield platform.
  • Application Development Services: Provides custom application development services to clients, generating revenue through project-based fees.
  • Partnerships and Alliances: Forms strategic partnerships with other companies to expand its reach and generate revenue through referral fees or revenue sharing agreements.

Branchenkontext

United Royale Holdings Corp., operating in the consumer defensive sector, specifically within the agricultural farm products industry, is pivoting towards technology with its TrueNorth Quantum subsidiary. The market for decentralized applications and secure connectivity solutions is growing, driven by increasing demand for data privacy and security. The company faces competition from established technology providers and other emerging players in the blockchain and PaaS space. The industry is characterized by rapid innovation and evolving regulatory landscapes, requiring companies to adapt quickly to stay competitive.

Wichtige Kunden

  • Financial Institutions: Targets banks, credit unions, and other financial institutions seeking secure and compatible technology solutions.
  • Healthcare Providers: Aims to serve hospitals, clinics, and other healthcare organizations looking to improve data security and interoperability.
  • Agtech Companies: Focuses on companies in the agricultural technology sector seeking to develop and deploy decentralized applications.
KI-Zuversicht: 69% Aktualisiert: 16. März 2026

Finanzdaten

Chart & Info

United Royale Holdings Corp. (URYL) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer URYL.

Kursziele

Wall-Street-Kurszielanalyse fuer URYL.

MoonshotScore

48/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von URYL auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Fuehrung: Gary Robert Bartholomew

Managing Director

Gary Robert Bartholomew is the managing director of United Royale Holdings Corp., overseeing the company's operations and strategic direction. With a background in technology and business management, Bartholomew is responsible for leading the company's efforts to develop and market the Northern Shield platform. His expertise includes product development, market analysis, and business strategy.

Erfolgsbilanz: Since assuming the role of managing director, Bartholomew has focused on positioning TrueNorth Quantum as a provider of secure and scalable decentralized application platforms. Key initiatives include the development and launch of the Northern Shield platform, as well as efforts to establish partnerships with companies in the financial, healthcare, and agtech sectors. His leadership is focused on driving innovation and growth within the company.

URYL OTC-Marktinformationen

The OTC Other tier represents the lowest tier of the OTC market, indicating that United Royale Holdings Corp. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited or no financial disclosure, making it difficult for investors to assess their financial health and performance. Investing in companies on the OTC Other tier carries significant risks due to the lack of transparency and regulatory oversight compared to exchanges like NYSE or NASDAQ.

  • OTC-Stufe: OTC Other
  • Offenlegungsstatus: Unknown
Liquiditaet: Liquidity for URYL is likely very limited due to its OTC Other listing and small market capitalization. This can result in wide bid-ask spreads, making it difficult to buy or sell shares at desired prices. Low trading volume can also lead to significant price fluctuations, increasing the risk of losses for investors.
OTC-Risikofaktoren:
  • Limited Financial Disclosure: The lack of publicly available financial information makes it difficult to assess the company's financial health and performance.
  • Low Liquidity: Limited trading volume and wide bid-ask spreads can make it challenging to buy or sell shares.
  • Regulatory Scrutiny: OTC Other companies are subject to less regulatory oversight than companies listed on major exchanges, increasing the risk of fraud or mismanagement.
  • Price Volatility: The stock price may be highly volatile due to the lack of liquidity and investor interest.
  • Going Concern Risk: The company's ability to continue operating as a going concern may be uncertain due to its financial condition.
Sorgfaltspruefung-Checkliste:
  • Verify the company's legal status and registration.
  • Obtain and review any available financial statements.
  • Assess the company's business model and competitive landscape.
  • Evaluate the management team's experience and track record.
  • Understand the risks associated with investing in OTC Other companies.
  • Consult with a qualified financial advisor.
  • Check for any regulatory actions or legal proceedings against the company.
Legitimitaetssignale:
  • Company has a functioning website and contact information.
  • Company has a registered office address.
  • CEO is publicly identified.
  • Company claims to have a working product (Northern Shield platform).
  • Company targets real-world industries (fintech, healthcare, agtech).

Haeufige Fragen zu URYL

What are the key factors to evaluate for URYL?

United Royale Holdings Corp. (URYL) currently holds an AI score of 48/100, indicating low score. Key strength: Proprietary Northern Shield platform.. Primary risk to monitor: Potential: Limited financial resources may hinder the company's ability to execute its growth strategy.. This is not financial advice.

How frequently does URYL data refresh on this page?

URYL prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven URYL's recent stock price performance?

Recent price movement in United Royale Holdings Corp. (URYL) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Proprietary Northern Shield platform.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider URYL overvalued or undervalued right now?

Determining whether United Royale Holdings Corp. (URYL) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying URYL?

Before investing in United Royale Holdings Corp. (URYL), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding URYL to a portfolio?

Potential reasons to consider United Royale Holdings Corp. (URYL) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Proprietary Northern Shield platform.. Additionally: Focus on high-growth sectors (fintech, healthcare, agtech).. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of URYL?

Yes, most major brokerages offer fractional shares of United Royale Holdings Corp. (URYL) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track URYL's earnings and financial reports?

United Royale Holdings Corp. (URYL) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for URYL earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Information is based on limited publicly available data.
  • OTC market investments carry significant risks.
  • AI analysis pending for URYL, which may provide additional insights.
Datenquellen

Popular Stocks